Alport Connect 2024, the annual Alport syndrome patient and family meeting in US

Published on 26/04/2024

27-28 July 2024
Denver, CA

ENYO Pharma is sponsoring and will attend Alport Connect 2024 organized by the American Alport Syndrome Foundation (ASF), the Alport syndrome patient-led non-profit organization in the US.

ENYO Pharma will meet patients and their families to present its starting Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients.

https://alportsyndrome.org/for-patients/alport-connect/

Read next in 'Events'

• The 2024 international workshop on Alport syndrome
• Alport Connect 2024, la rencontre annuelle américaine avec les patients atteints du syndrome d’Alport
• ASN Kidney Week 2024
• ASN Kidney Week 2024
• The 2024 international workshop on Alport syndrome